Navigation Links
Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
Date:3/9/2009

eceive 1200-mcg albinterferon alfa-2b; and 21.6% (162/750) in patients randomized to receive 180-mcg peginterferon alfa-2a.

About the Design of the ACHIEVE 1 Trial

In the randomized, multi-center, active-controlled non-inferiority ACHIEVE 1 Phase 3 trial, 1331 treatment-naive patients with genotype 1 chronic hepatitis C were initially assigned to one of three treatment groups, including two groups that received subcutaneously administered albinterferon alfa-2b once every two weeks at doses of 900 mcg or 1200 mcg, and an active control group that received peginterferon alfa-2a once weekly at a dose of 180 mcg - with all patients receiving daily oral ribavirin concomitantly. In January 2008, a dose modification was made for patients originally assigned to receive the 1200-mcg dose of albinterferon alfa-2b. These patients had their dose modified to 900-mcg albinterferon alfa-2b every two weeks. Following the dose modification, the study continued to follow all patients randomized into the trial on an intention-to-treat (ITT) basis according to their original dose assignment. The primary data analysis compares the 900-mcg albinterferon alfa-2b treatment group to the peginterferon alfa-2a treatment group. The trial included 48 weeks of treatment, and the primary efficacy endpoint was sustained virologic response (SVR), defined as undetectable viral load (HCV RNA<10 IU/mL) at Week 72 (24 weeks following completion of treatment). A total of 2,264 patients with chronic hepatitis C have participated in the two Phase 3 trials of albinterferon alfa-2b.

About Albinterferon Alfa-2b (Albuferon)

Albinterferon alfa-2b is a genetic fusion of human albumin and interferon alfa created using the proprietary HGS albumin-fusion technology. Human albumin is the most prevalent naturally occurring blood protein in the human circulatory system, persisting in circulation in the body for approximately 1
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Drug Development Program Started Based on CAP(R) Human Cell Line
2. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
3. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
4. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
5. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
6. Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs
7. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
8. Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation
9. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
10. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
11. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... SAN DIEGO , July 10, 2014  RESMED INC. ... report its fourth quarter and fiscal year ended June 30, ... York Stock Exchange market close. A press release with ResMed,s ... and the company will host a webcast to discuss operating ... scheduled to begin at 1:30 p.m. US Pacific Time and ...
(Date:7/10/2014)... July 10, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... it has completed the sale to Galderma of all ... or held by Valeant for $1.4 billion in cash, ... which recently completed its acquisition of Galderma. ... our products to a company that is firmly committed ...
(Date:7/10/2014)... July 10, 2014   LabStyle Innovations Corp ... today announced the appointment of Professor Richard ... its Board of Directors. Prof. Stone ... experience to LabStyle as an entrepreneur, venture capitalist ... corporate governance expert. He currently serves on the ...
Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4
... SimplyGo Portable Oxygen Concentrator by Philips Resironics is ... and pulse does at a weight of only 10 pounds.  ... continuous flow portable concentrator weighed in at a hefty 19 ... anywhere you go in the world you can plug the ...
... federal judge in New York has thrown out the case [1] ... of investment fund manager Porton Group, in the latest development in ... 3M that Mr Boulter had attempted to "blackmail" the company were ... follows the decision earlier this month of a court in Washington ...
Cached Medicine Technology:SimplyGo Portable Oxygen Concentrator Now Available 2Blackmail Claims Against Harvey Boulter Thrown out of Court 2
(Date:7/12/2014)... (PRWEB) July 12, 2014 ... & Peripheral Vascular Devices Market by ... Drug-Eluting), Catheter (IVUS, OCT), IVC Filter ... to 2018" analyzes and studies the ... in the U.S. and Canada. , ...
(Date:7/12/2014)... Demand Response Management Systems is a crucial peak load ... between energy supply and demand. With the help of ... to increasing pressure on the grid) and replaced by ... appliances and thermostats for load reduction. , DRMS ... with government mandates and benefits for energy efficiency and ...
(Date:7/12/2014)... The fastest-growing mobile technology is LTE (Long ... LTE networks continues to grow due to the rapid ... increased mobile data traffic, which is a major driver ... Test and Measurement equipment comply with industry standards, and ... and Measurement Market is estimated to grown from $3.75 ...
(Date:7/12/2014)... Casinos in Australia have grown ... international and online casinos. Revenue is estimated to increase ... through 2014-15. Greater per capita gambling expenditure has assisted ... in discretionary income levels have also assisted revenue growth, ... such as casino gambling services. Revenue is estimated to ...
(Date:7/12/2014)... News) -- Burn injuries increase in the summer as people ... experts. Among those most vulnerable to these seasonal fire hazards: ... often get burned by putting their hands on the side ... burn unit at Loyola University Medical Center in Maywood, Ill., ... of ,When you play with fire, you get burned, is ...
Breaking Medicine News(10 mins):Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 5Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Burn Injuries More Common in Summer 2
... Minister Dr Anbumani Ramadoss has decided to launch a ban on ... happens, very soon the colas and junk food may be out ... that: “Colas and junk food are bad for children’s health. Hence, ... school premises,” is in talk with Union Human Resource Development Ministry ...
... children who are intelligent are more likely to turn ... though researchers are unclear about vegetarianism's link to IQ ... Catharine Gale at England's University of Southampton, studied 8,170 ... edition of health magazine WebMD., ,Participants took an ...
... cancer were almost four times as successful when they took ... more likely to spot polyps, according to the study. ... tube with a tiny camera into the colon. The colonoscopy ... cancerous and pre-cancerous growths. ,On an average, it ...
... a chemical treatment to remove lead from the body -- ... lead exposure, a// Cornell study of young rats finds. ... the treatment of autistic children, the researchers say that when ... the lead-removing chemical, they showed declines in their learning and ...
... schools, such as soft drink ads; the use ... from soft drink bottlers; and exclusive// beverage contracts ... researchers. ,Dr. Claudia Probart, Penn ... the study, says, 'Schools' newly created wellness policies ...
... Researchers at the University of Pennsylvania’s School of Medicine ... on Medicare quality measures// had little difference in the ... hospitals, indicating that the performance measures may not accurately ... PhD, Assistant Professor of Medicine at the University of ...
Cached Medicine News:Health News:Colonoscopies Can Help Prevent Colon Cancer; Only When Done Properly 2Health News:Pros and Cons of Therapy for Lead Exposure 2Health News:Marketing in Schools may Discourage Healthy Nutrition among Students 2Health News:Hospital Performance Measures May Not Make Much Difference When It Comes to Mortality 2
... Series 1000 Power Instrument System is ... offers versatility and convenience with modular ... Module, without hand throttle, for use ... foot pedal. Accepts all 1000 and ...
... The Brasseler USA™ Battery Packs contain ... age have a great impact upon battery ... is necessary. Any deviation from these recommendations ... are sensitive to heat. Any exposure of ...
Pneumatic High-speed Drill, Throttleless, 90k Rpm, Microaire Connector....
Pneumatic oscillating saw, 35k cpm, available with various hose connector styles....
Medicine Products: